Every 10-Q that Masimo Corporation (MASI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MASI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MASI filings page.
Masimo Corporation reported stronger results for the quarter ended April 4, 2026 and highlighted its pending cash acquisition by Danaher. Total revenue from continuing operations was $403.6 million, up from $372.0 million a year earlier, driven mainly by healthcare monitoring products.
Net income was $57.1 million, compared with a loss of $170.7 million in the prior-year period that included large discontinued-operations charges. Continuing operations earned $1.09 diluted income per share. Operating income held steady at $77.4 million despite $17.9 million of merger-related costs in selling, general and administrative expenses.
Masimo agreed to be acquired by Danaher, with each share of Masimo common stock to be converted into the right to receive $180.00 in cash, subject to customary conditions and regulatory approvals. The deal was adopted by stockholders, and Masimo expects to delist its shares if the merger closes.
Masimo Corporation reported third‑quarter results reflecting solid performance in healthcare operations and the completion of its consumer audio divestiture. Total revenue was $371.5M, up from $343.3M a year ago, with operating income rising to $83.6M from $38.2M. Net income from continuing operations was $53.7M versus $24.3M last year, while the company recorded a net loss from discontinued operations of $(154.1)M tied to the sale of Sound United.
Masimo closed the Sound United sale on September 23, 2025. On the balance sheet, cash and cash equivalents increased to $312.3M from $123.6M, and long‑term debt declined to $559.1M from $714.3M. Year‑to‑date, operating cash flow was $157.3M and investing cash flow was $283.8M, aided by discontinued operations. Financing cash flow was $(306.1)M, including repurchases of common stock of $177.0M. Shares outstanding were 53,713,949 as of September 27, 2025.